Research Article
Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection
Table 2
XMRV nucleic acid and antibody results.
| | Subject ID | XMRV average RNA copies/mL by X-SCA | XMRV DNA copies per 1e6 cells by X-SCA | ARCHITECT antibody serology | Western blot | XMRV status |
| | 201 | <10 | <1 | neg | NT | neg | | 202 | <10 | <1 | neg | NT | neg | | 203 | <10 | <1 | neg | NT | neg | | 204 | <9 | <1 | neg | NT | neg | | 205 | <18 | <1 | neg | NT | neg | | 206 | <9 | <1 | neg | NT | neg | | 207 | <9 | <1 | neg | NT | neg | | 208 | <9 | <1 | neg | NT | neg | | 209 | <9 | <1 | neg | NT | neg | | 210 | <9 | <1 | gp70+ | neg | neg | | 211 | <9 | <1 | gp70+ | neg | neg | | 212 | <9 | <1 | neg | NT | neg | | 213 | <9 | <1 | neg | NT | neg | | 214 | <9 | <1 | neg | NT | neg | | 215 | <18 | <1 | gp70+ | gp70+ | neg | | 216 | <9 | <1 | neg | NT | neg | | 217 | <9 | <1 | gp70+ | neg | neg | | 218 | 61 | <1 | neg | NT | neg | | 219 | <9 | <1 | neg | NT | neg | | 220 | <9 | <1 | neg | NT | neg | | 221 | <9 | <1 | neg | NT | neg | | 222 | <9 | <1 | p15E+ | p15E+, p30+ | neg | | 223 | <9 | <1 | neg | NT | neg | | 224 | <9 | <1 | neg | NT | neg | | 225 | <9 | <1 | neg | NT | neg | | 226 | <9 | <1 | neg | NT | neg | | 227 | <9 | <1 | gp70+ | p30+ | neg | | 228 | <9 | <1 | neg | NT | neg | | 229 | <9 | <1 | gp70+ | neg | neg | | 230 | <9 | <1 | neg | NT | neg | | 231 | <9 | <1 | gp70+ | neg | neg | | 232 | <9 | <1 | neg | NT | neg | | 233 | <9 | <1 | gp70+ | neg | neg | | 234 | <9 | <1 | neg | NT | neg |
|
|
*NT indicates that MACS ID was not tested by Western blot assay.
|